The price of ADMA is predicted to go up 82.77%, based on the high correlation periods with FOSL. The similarity of these two price pattern on the periods is 95.73%.

ADMA

FOSL

Up: 82.77%Similarity: 95.73%

ADMA Revenue Forecast

ADMA EPS Forecast

ADMA FAQs

What is bull’s view on ADMA?

ADMA Biologics (ADMA) is currently trading at $16.17, with analysts projecting significant earnings growth of 275% year-over-year in the upcoming report. However, the stock has underperformed recently, declining 7.43% over the past month, and is trading at a premium valuation with a Forward P/E of 23.64, slightly above the industry average. Bullish investors may see potential upside if earnings exceed expectations, but caution is advised due to the lack of immediate catalysts and recent price weakness.

What is bear's view on ADMA?

ADMA stock closed at $16.16 on January 31, 2025, showing a slight gain of 0.31%. Analysts suggest caution due to its premium valuation (Forward P/E of 23.64) and lack of immediate catalysts, as highlighted by Jim Cramer. A bearish view would recommend waiting for a price drop or clearer financial performance before considering investment.